VWM
ABBV icon

VCI Wealth Management’s AbbVie ABBV Stock Holding History

VCI Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3M Buy
+9,136
New +$1.97M 0.58% 49
2026
Q1 		– Sell
-12,008
Closed -$2.74M – 124
2025
Q4 		$2.74M Buy
+12,008
New +$2.74M 0.76% 31
2025
Q3 		– Sell
-9,028
Closed -$1.68M – 116
2025
Q2 		$1.68M Buy
9,028
+1,414
+19% +$263K 0.59% 41
2025
Q1 		$1.6M Buy
+7,614
New +$1.48M 0.67% 34

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

VCI Wealth Management's ABBV Position: Q2 2026 in Review

VCI Wealth Management opened a new position in AbbVie (ABBV) in Q2 2026: 9,136 shares worth $2.3M. The stake represents 0.58% of the portfolio and ranks #49 among its holdings. This is a return to the name: VCI Wealth Management previously reported a position in ABBV as recently as Q4 2025.

VCI Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $2.74M in Q4 2025. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • VCI Wealth Management held 9,136 shares of AbbVie worth $2.3M as of Q2 2026.
  • AbbVie was a new VCI Wealth Management position in Q2 2026.
  • AbbVie made up 0.58% of VCI Wealth Management's portfolio in Q2 2026, its #49 holding.
  • VCI Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
  • VCI Wealth Management's AbbVie position peaked at $2.74M in Q4 2025.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on VCI Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.